Table 2. Risk factors included across the existing TAVI-specific CPMs that aim to predict 1-year mortality.

Characteristic	CoreValve model (18)	TARIS (24)	TAVI2-SCOREe (25)
Year of publication	2016	2014	2015
Total sample size	3,687	1,178	511
Derivation	2,482	845	511
Validation*	1,205	333	100 (bootstrap resampling)
Predictors	Albumin ≤3.3 g/dL	Age	Age >85 years
	Home oxygen	Female	Male
	Severe Charlson score	BMI	Porcelain aorta
	STS-PROM >7%	Pulmonary hypertension	MI <90 days
		eGFR	CrCl <30 mL/kg/min
		Hemoglobin	Hemoglobin <10 g/dL
		P mean before TAVI (mmHg)	LVEF <35%
		LVEF <45%	Aortic valve mean gradient ≥70 mmHg

*, Internal validation. TAVI, transcatheter aortic valve implantation; CPMs, clinical prediction models; BMI, body mass index; CrCl, creatinine clearance; eGFR, glomerular filtration rate; LVEF, left ventricular ejection fraction; MI, myocardial infarction; STS-PROM, Society of Thoracic Surgeons Predicted Risk of Mortality.